2023-08-18 12:35:05
By Marie Bartnik
Posted 3 hours ago, Updated 2 hours ago
The vaccination campaign will begin in October. Blair Gable/REUTERS
The vaccination campaign once morest covid will start in France in mid-October. Only the Pfizer vaccine will be available there.
The start of the school year has not yet started and the covid has already returned, thanks to a new variant, Eris. The vaccines expected in the fall in pharmacies will nonetheless be effective once morest covid 19, assure the main vaccine manufacturers.
According to the agency Archyde.com, Pfizer said on Thursday that the most recent version of its vaccine, dubbed Comirnaty, has also been shown to be effective once morest Eris in tests with mice. Moderna also sees arobust immune responsefollowing the injection of its vaccine, both once morest Eris, the variant now dominant in the United States, and once morest Fornax, another variant on the rise in certain American states. “These new results reflect the capacity of our vaccine to face the threat of new variants of covid 19“Said Stephen Hoge, president of Moderna.
Eris is a derivative of the XBB.1.5 subline of the Omicron variant.
Read alsoCovid-19: what is “Eris”, the new variant that is gaining ground in France?
France is currently experiencing a resurgence of contamination with the covid virus. According to Public Health France, its incidence is slightly increasing in all age groups. “The slight increase in indicators already observed in previous weeks continues but the indicators still remain at low levels“, notes the organization. The incidence rate of covid 19 in France has risen from 7.7 to 12.3 laboratory-confirmed cases per 100,000 inhabitants – which represented 8,351 cases only last week.
New variants
The vaccination campaign should begin in the fall. “The first doses of vaccine will arrive in pharmacies from mid-Octoberspecifies Philippe Besset, the president of the Federation of Pharmaceutical Unions of France. The covid vaccination campaign will take place at the same time as the flu vaccination and will target the same audiences “. The High Authority of Health recommends this year only people over 65 and vulnerable people to be injected with a booster dose. Unlike last year, the Pfizer vaccine will be the only one available in pharmacies, the laboratory having won the call for tenders issued by the European Union.
For laboratories that have developed a vaccine once morest covid, however, the good times are over. As part of the contract signed in May with Pfizer-BioNTech, the EU obtained a reduction in the number of doses purchased by the States and the possibility of having them delivered over four years. The results of Pfizer, BioNTech and Moderna thus suffered from a sharp drop in demand for vaccines compared to last year. In the second quarter, Moderna posted a quarterly net loss of $ 1.4 billion, and sales related to Covid vaccines of 293 million, down 94%. Sales of Pfizer’s Comirnaty vaccine have dropped by 83% in one year.
In France, only a fraction of the population is called upon to be vaccinated. “But this population which is also vaccinated once morest the flu is generally respectful of the recommendations of the High Authority of Healthnuance Philippe Besset. It is also easier to get the population to accept vaccination at the rate of once a year than every three months as before.».
There remains the unknown of the irruption of new variants resistant to vaccines, which might relaunch the race for vaccines. The World Health Organization and US health authorities announced on Friday that they are closely monitoring a new variant of Covid-19 presenting a “very large number (more than 30) of mutations of the Spike gene that he carries“. This new variant has so far only been detected in Israel, Denmark and the United States.
”
data-script=”https://static.lefigaro.fr/widget-video/short-ttl/video/index.js”
>
1692375385
#Pfizer #Moderna #vaccines #expected #effective #Eris #variant
